Crossmark

Exploring SLC30A6 as a potential prognostic, immunomodulatory, and therapeutic biomarker in various cancers with a focus on pancreatic cancer: a pan-cancer analysis

Crossref DOI link: https://doi.org/10.1186/s43042-024-00608-0

Published Online: 2024-11-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Maghool, Fatemeh

Kadkhodaei Elyaderani, Parisa

Mohammadzadeh, Samaneh

Hosseini, Amir

Heidari, Aida

Samadi, Pouria https://orcid.org/0000-0002-6999-9946
License Information

Text and Data Mining valid from 2024-11-19

Version of Record valid from 2024-11-19
More Information

Article History

Received: 26 June 2024

Accepted: 7 November 2024

First Online: 19 November 2024

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below